Assistant Professor of Medicine at Stanford University
Palo Alto, CA
Joined December 2014
- Tweets67
- Following127
- Followers1.1K
- Likes147
We're excited to release SpatialWhisperer, a trimodal model for zero-shot annotation of histopathology images at #ICML2026! This work is lead by Moritz Schaefer @muronglizi.
Cancer diagnosis is informed by cellular annotations of histopathology, but assays are expensive or rely on manual annotations.
At #ICML2026, we present SpatialWhisperer, a trimodal model that zero-shot annotates cell types in histopathology images. 🧵👇
This work has been led by Moritz Schaefer @muronglizi in close collaboration with @jure and @BockLab labs, Zoe Piran @zoe_piran, and Nils Walter @Animesh0303.
Grateful to the Stanford Center for Digital Health for supporting our work with @jure on prototyping AI models and agents for T cell therapy design.
We're excited to introduce the 2026 Stanford Center for Digital Health Grant Awardees, a cohort of scientists working on projects that can transform health. Please join us in celebrating this exceptional group of researchers from across @stanford. cdh.stanford.edu/research-po…
Zinaida Good retweeted
We asked the best AI researchers in the world one question: if you had the resources, how would you use AI to solve humanity's hardest problems?
Today we're sharing what came back.
Moonshots // ONE is live. 🧵 laude.org/moonshots
Zinaida Good retweeted
Excited to present the first major work after starting our lab at Stanford and the Arc this year: CRISPR-All, a unified genetic perturbation language for programming any major type of genetic perturbation simultaneously, in any combination, at genome scale, in human cells.
We're excited to release tcellMIL, an attention-based multiple instance learning model for predicting patient outcomes after CAR T cell therapy for lymphoma and nominating cell design strategies in #neurips2025 AI4D3! ai4d3.github.io/2025/papers/…
It's exciting to share our mini-review on #Treg cell therapies out today in Frontiers in Immunology! Earning a #NobelPrize this year, Tregs have been tested in >69 clinical trials and are moving towards initial approvals. frontiersin.org/journals/imm…
Today is my first day as an Assistant Professor of Medicine at Stanford University! My research program is focused on understanding and enhancing engineered T cell immunotherapies for cancer and immune-mediated diseases. If interested in joining please reach out!
This would not be possible without my mentors, especially Crystal Mackall, @sylviaplevritis, @GarryPNolan, Sean Bendall, David Miklos, and Michael Gold - THANK YOU!
Very proud of Anne Marijn Kramer to present 2 orals and a poster at #ASH2024, especially our work on CD22-CAR!
Session 702
Dec 9 at 2:45 PM
San Diego Convention Center, Room 6CF
Title: CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with IEC-HS
So proud of Kelvin Mo to give his first talk at #ASH2024!
Session 702
Dec 7 at 4:00 PM
Manchester Grand Hyatt San Diego, Grand Hall C
Title: CCL8/CCL13-Producing Tumor-Associated Macrophages Linked to Poor Outcomes after CAR T Cell Therapy for LBCL
What an honor to give my first invited talk at #ASH2024. I am so grateful to my mentors Crystal Mackall, Sylvia Plevritis, and David Miklos for enabling me to get here!
Dec 8 at 4:30 PM, San Diego Conv. Center, Room 33
Cellular Heterogeneity and Relationship to Clinical Outcomes
Our Stanford Center for Cancer Cell Therapy is excited to offer a Postdoctoral Fellow position at the interface between machine learning and T cell therapies: postdocs.stanford.edu/prospe…
Zinaida Good retweeted
Boom Capital is hiring a Chief of Staff. 🚀 This is one of our most important hires. You'll liaise with our in-house scientific society and impact every aspect of a VC firm, serving unprecedented ideas, scientists and engineers. Join boomcap.co and apply here: tinyurl.com/2xm65tja
Grateful to give an invited talk at the 6th Annual #Treg-Directed Therapies Summit! Please join us in Boston this May 21-23.
treg-directed-therapies.com/
Humbled and grateful to be selected as a 2023 Bridge Fellow by the @parkerici to push forward CAR T immunotherapy research. parkerici.org/the-latest/ecr…
Grateful to @CGT_Live to publish this summary of our work with @MackallLab, David Miklos, @BitaSahaf and team that I presented at @AACR! cgtlive.com/view/lineage-tra…